MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2016 International Congress

    Neuropsychological assessment in a cohort of patients with Parkinson’s disease

    C. Juri, W. Uslar, H. Farias, M. Vasquez (Santiago, Chile)

    Objective: To evaluate the cognitive profile in a cohort of patients with Parkinson's disease (PD) using a standardised battery. Background: Cognitive impairment is a great…
  • 2016 International Congress

    Rapid eye movement sleep behavior disorder symptoms correlate with domains of cognitive impairment in Parkinson’s disease

    J.R. Zhang, J. Chen, Z.J. Yang, H.J. Zhang, Y.T. Fu, Y. Shen, P.C. He, C.J. Mao, C.F. Liu (Suzhou, People's Republic of China)

    Objective: To investigate (1) the domains of cognitive impairment in patients with Parkinson's disease (PD) and rapid eye movement sleep behavior disorder (RBD). (2) To…
  • 2016 International Congress

    Dopamine modulates learning conflicting action-valence associations in Parkinson’s disease

    N.C. van Wouwe, D.O. Claassen, J.S. Neimat, S.A. Wylie (Nashville, TN, USA)

    Objective: To investigate the effect of dopaminergic medication in Parkinson's disease (PD) on learning to act and learning to withhold action based on rewarding versus…
  • 2016 International Congress

    Staging of cognitive impairment: Validation of a novel cognitive score with [18F]FDG-PET

    D. Blum, M. Reimold, W. Maetzler, C. la Fougère, G. Reischl, D. Berg, I. Liepelt-Scarfone (Tübingen, Germany)

    Objective: To provide insight into the nature of cognitive deterioration and Parkinson's disease dementia (PDD) and to validate a novel cognitive score (also submitted for…
  • 2016 International Congress

    Treatment with the use of the PD-specific scales for patients suffering from subcortical Parkinsonian dementia

    N.G. Sokhibnazarov, F.K. Shermukhamedova (Tashkent, Uzbekistan)

    Objective: Aim of this study was to identify the degree of cognitive dysfunction in patients with subcortical Parkinsonian dementia, during the neuroprotective therapy. Background: Parkinson's…
  • 2016 International Congress

    Comparative study patients with different clinical forms of Parkinson’s disease

    N.D. Demchuk, T.V. Yakovleva, Y.V. Karakulova (Perm, Russia)

    Objective: To study the cognitive, emotional status, sleep disturbances in patients with akinetic-rigid and tremor form of Parkinson's disease (PD). Background: Parkinson's disease (PD) -…
  • 2016 International Congress

    Face and color recognition after subthalamic nucleus stimulation in Parkinson’s disease

    A. Gündüz, S. Yagci, S. Aydin, B.Ç. Poyraz, G. Genç, S. Oguz, H. Apaydin, G. Kiziltan, H. Hanagasi, M. Hanci, S. Ertan (Istanbul, Turkey)

    Objective: We hypothesized that face recognition and color perception may also be impaired after STN DBS and we tested our hypothesis in a group of…
  • 2016 International Congress

    Cognitive profile in the Parkinsonian variant of multiple system atrophy: Findings from a Tunisian cohort

    A. Nasri, M. Ben Djebara, I. Kacem, Y. Sidhom, A. Gargouri, R. Gouider (Tunis, Tunisia)

    Objective: To establish the cognitive profile of MSA-P in a Tunisian cohort and to discuss its association with motor signs. Background: It has been previously…
  • 2016 International Congress

    Parkinsonism risk factors in Salt Lake City, Utah

    D. Shprecher, K. Gannon, M. Halverson, R. Savica (Sun City, AZ, USA)

    Objective: To assess the prevalence of risk factors for parkinsonism in Salt Lake City (SLC), Utah. Background: Recent data suggest that non-motor symptoms including constipation,…
  • 2016 International Congress

    Protein levels of SV2A and VGLUT1 in brain tissue from patients with Parkinson’s disease, dementia with Lewy bodies and Alzheimer’s disease

    S. Frykman, M. Oosterhof, M.S. Ahmed, D. Howlet, T. Hortobagyi, P. Francis, D. Årsland (Huddinge, Sweden)

    Objective: The objective of this study was to investigate whether SV2A and/or VGLUT1 are suitable as markers for synaptic degeneration in neurodegenerative disorders and could…
  • « Previous Page
  • 1
  • …
  • 106
  • 107
  • 108
  • 109
  • 110
  • …
  • 117
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley